Environmental sampling of pharmacy's clean room revealed presence of microorganisms and fungal growth.
Franck’s Pharmacy has issued a recall of all sterile human and veterinary compounded prescriptions that were distributed dating back to November 21, 2011. The U.S. Food and Drug Administration (FDA) recently notified the pharmacy, based in Ocala, Fla., that an environmental sampling of their clean room revealed the presence of microorganisms and fungal growth, which presents a possible risk of infection and subsequent patient illness.
Anyone in possession of these sterile preparations should discontinue their use and destroy any remaining quantities. Any adverse events that have resulted from the use of these recalled products should be reported immediately to Franck’s Pharmacy and FDA’s MedWatch program.
Questions regarding the recall should be directed to Franck’s Pharmacy at (352) 690-6773, Monday through Friday from 9 a.m. to 5 p.m. EST.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More